MKK7 and ARF: New players in the DNA damage response scenery

Cell Cycle

Volumn 13, Issue 8, 2014, Pages 1227-1236

  Kotsinas, Athanassios ^a   Papanagnou, Panagiota ^a   Galanos, Panagiotis ^a   Schramek, Daniel ^b   Townsend, Paul ^c,d   Penninger, Josef M ^e   Bartek, Jiri ^f,g   Gorgoulis, Vassilis G ^a,c,d,h  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^g PALACKÝ UNIVERSITY   (Czech Republic)

^h BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Anti tumor barrier; ARF; DNA damage response; Feedback loop; MKK7; p38 MAPK; p53; Replication stress; Senescence; Wip 1

Indexed keywords

ARF PROTEIN; DNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; PROTEIN P53; ATM PROTEIN; ATM PROTEIN, HUMAN; ATR PROTEIN, HUMAN; MAP2K7 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; AUTOREGULATION; CELL SURVIVAL; DNA DAMAGE; DNA DAMAGE RESPONSE; GENOTOXICITY; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; SIGNAL TRANSDUCTION; STRESS; ANIMAL; DNA REPAIR; METABOLISM; PHOSPHORYLATION; READING FRAME;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; DNA DAMAGE; DNA REPAIR; HUMANS; MAP KINASE KINASE 7; ONCOGENES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; READING FRAMES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84899066730     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.28654     Document Type: Article

References (75)

1. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability - an evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010; 11:220-8; PMID:20177397; http://dx.doi.org/10.1038/nrm2858
2. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009; 461:1071-8; PMID:19847258; http://dx.doi.org/10.1038/ nature08467
3. Bartkova J, Horejsí Z, Koed K, Krämer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434:864-70; PMID:15829956; http://dx.doi.org/10.1038/nature03482
4. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr., Kastrinakis NG, Levy B, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434:907-13; PMID:15829965; http://dx.doi.org/10.1038/ nature03485
5. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444:633-7; PMID:17136093; http://dx.doi.org/10.1038/ nature05268
6. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre' M, Nuciforo PG, Bensimon A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638-42; PMID:17136094; http://dx.doi.org/10.1038/nature05327
7. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008; 319:1352-5; PMID:18323444; http://dx.doi.org/10.1126/science.1140735
8. Schramek D, Kotsinas A, Meixner A, Wada T, Elling U, Pospisilik JA, Neely GG, Zwick RH, Sigl V, Forni G, et al. The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression. Nat Genet 2011; 43:212-9; PMID:21317887; http://dx.doi.org/10.1038/ng.767
9. Velimezi G, Liontos M, Vougas K, Roumeliotis T, Bartkova J, Sideridou M, Dereli-Oz A, Kocylowski M, Pateras IS, Evangelou K, et al. Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer. Nat Cell Biol 2013; 15:967-77; PMID:23851489; http://dx.doi.org/ 10.1038/ncb2795
10. Evangelou K, Bartkova J, Kotsinas A, Pateras IS, Liontos M, Velimezi G, Kosar M, Liloglou T, Trougakos IP, Dyrskjot L, et al. The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis. Cell Death Differ 2013; 20:1485-97; PMID:23852374; http://dx.doi.org/10.1038/cdd.2013.76
11. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005; 24:2899-908; PMID:15838523; http://dx.doi.org/10.1038/sj. onc.1208615
12. Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ 2006; 13:1027-36; PMID:16557269; http://dx.doi.org/10.1038/sj.cdd.4401910
13. Kruse JP, Gu W. Modes of p53 regulation. Cell 2009; 137:609-22; PMID:19450511; http://dx.doi.org/10.1016/j.cell.2009.04.050
14. Lu X. Tied up in loops: positive and negative auto-regulation of p53. Cold Spring Harb Perspect Biol 2010; 2:a000984; PMID:20452957; http://dx.doi.org/10.1101/cshperspect.a000984
15. Horn HF, Vousden KH. Coping with stress: multiple ways to activate p53. Oncogene 2007; 26:1306-16; PMID:17322916; http://dx.doi.org/10.1038/sj.onc. 1210263
16. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E, Fornace AJ Jr. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 1999; 18:6845-54; PMID:10581258; http://dx.doi.org/10.1093/emboj/18.23.6845
17. Takekawa M, Adachi M, Nakahata A, Nakayama I, Itoh F, Tsukuda H, Taya Y, Imai K. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J 2000; 19:6517-26; PMID:11101524; http://dx.doi.org/10.1093/emboj/19.23.6517
18. Le Guezennec X, Bulavin DV. WIP1 phosphatase at the crossroads of cancer and aging. Trends Biochem Sci 2010; 35:109-14; PMID:19879149; http://dx.doi.org/10.1016/j.tibs.2009.09.005
19. Lu X, Nannenga B, Donehower LA. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev 2005; 19:1162-74; PMID:15870257; http://dx.doi.org/10.1101/gad.1291305
20. Shreeram S, Demidov ON, Hee WK, Yamaguchi H, Onishi N, Kek C, Timofeev ON, Dudgeon C, Fornace AJ, Anderson CW, et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol Cell 2006; 23:757-64; PMID:16949371; http://dx.doi.org/10.1016/j.molcel.2006.07.010
21. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, Appella E, Fornace AJ Jr. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)- p19(Arf) pathway. Nat Genet 2004; 36:343-50; PMID:14991053; http://dx.doi.org/ 10.1038/ng1317
22. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83:993-1000; PMID:8521522; http://dx.doi.org/10.1016/0092-8674(95)90214-7
23. Chen D, Kon N, Zhong J, Zhang P, Yu L, Gu W. Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression. Mol Cell 2013; 51:46-56; PMID:23747016; http://dx.doi.org/10.1016/j.molcel.2013.05.006
24. Bertwistle D, Sugimoto M, Sherr CJ. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 2004; 24:985-96; PMID:14729947; http://dx.doi.org/10.1128/MCB.24.3.985-996.2004
25. Sherr CJ. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 2006; 6:663-73; PMID:16915296; http://dx.doi.org/10.1038/nrc1954
26. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A 1998; 95:8292-7; PMID:9653180; http://dx.doi.org/10.1073/ pnas.95.14.8292
27. Pomerantz J, Schreiber-Agus N, Liégeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998; 92:713-23; PMID:9529248; http://dx.doi.org/10.1016/S0092- 8674(00)81400-2
28. Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 2000; 19:2312-23; PMID:10822382; http://dx.doi.org/10.1038/sj.onc.1203593
29. Tavana O, Chen D, Gu W. Controlling ARF stability: New players added to the team. Cell Cycle 2014; 13:497-8; PMID:24419106; http://dx.doi.org/10.4161/ cc.27786
30. Sugimoto M, Kuo ML, Roussel MF, Sherr CJ. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol Cell 2003; 11:415-24; PMID:12620229; http://dx.doi.org/10.1016/S1097-2765(03)00057-1
31. Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 2003; 12:1151-64; PMID:14636574; http://dx.doi.org/10.1016/S1097-2765(03)00431-3
32. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, et al. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998; 17:5001-14; PMID:9724636; http://dx.doi.org/10.1093/emboj/17. 17.5001
33. Tournier C, Dong C, Turner TK, Jones SN, Flavell RA, Davis RJ. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev 2001; 15:1419-26; PMID:11390361; http://dx.doi.org/10.1101/gad.888501
34. Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T, Davis RJ. The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases. Mol Cell Biol 1999; 19:1569-81; PMID:9891090
35. Fleming Y, Armstrong CG, Morrice N, Paterson A, Goedert M, Cohen P. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem J 2000; 352:145-54; PMID:11062067; http://dx.doi.org/10.1042/ 0264-6021:3520145
36. Adjei AA. Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 2001; 93:1062-74; PMID:11459867; http://dx.doi.org/10.1093/jnci/93. 14.1062
37. Coles C, Condie A, Chetty U, Steel CM, Evans HJ, Prosser J. p53 mutations in breast cancer. Cancer Res 1992; 52:5291-8; PMID:1394133
38. Cui J, Zhang M, Zhang YQ, Xu ZH. JNK pathway: diseases and therapeutic potential. Acta Pharmacol Sin 2007; 28:601-8; PMID:17439715; http://dx.doi.org/10.1111/j.1745-7254.2007.00579.x
39. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009; 9:537-49; PMID:19629069; http://dx.doi.org/10.1038/nrc2694
40. Rayter S, Elliott R, Travers J, Rowlands MG, Richardson TB, Boxall K, Jones K, Linardopoulos S, Workman P, Aherne W, et al. A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D. Oncogene 2008; 27:1036-44; PMID:17700519; http://dx.doi.org/10.1038/sj.onc.1210729
41. Haigis KM, Sweet-Cordero A. New insights into oncogenic stress. Nat Genet 2011; 43:177-8; PMID:21350495; http://dx.doi.org/10.1038/ng0311-177
42. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004; 432:307-15; PMID:15549092; http://dx.doi.org/10.1038/nature03098
43. Palmero I, Pantoja C, Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature 1998; 395:125-6; PMID:9744268; http://dx.doi.org/10.1038/25870
44. Kamijo T, van de Kamp E, Chong MJ, Zindy F, Diehl JA, Sherr CJ, McKinnon PJ. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. Cancer Res 1999; 59:2464-9; PMID:10344759
45. Efeyan A, Garcia-Cao I, Herranz D, Velasco-Miguel S, Serrano M. Tumour biology: Policing of oncogene activity by p53. Nature 2006; 443:159; PMID:16971940; http://dx.doi.org/10.1038/443159a
46. Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA, Brown-Swigart L, Johnson L, Evan GI. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 2008; 14:447-57; PMID:19061836; http://dx.doi.org/10.1016/j.ccr.2008.10.018
47. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
48. Tang X, Hui ZG, Cui XL, Garg R, Kastan MB, Xu B. A novel ATM-dependent pathway regulates protein phosphatase 1 in response to DNA damage. Mol Cell Biol 2008; 28:2559-66; PMID:18250156; http://dx.doi.org/10.1128/MCB.01711-07
49. rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160-6; PMID:17525332; http://dx.doi.org/10.1126/science. 1140321
50. Chen D, Shan J, Zhu WG, Qin J, Gu W. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses. Nature 2010; 464:624-7; PMID:20208519; http://dx.doi.org/10.1038/nature08820
51. Liontos M, Koutsami M, Sideridou M, Evangelou K, Kletsas D, Levy B, Kotsinas A, Nahum O, Zoumpourlis V, Kouloukoussa M, et al. Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior. Cancer Res 2007; 67:10899-909; PMID:18006835; http://dx.doi.org/10.1158/0008-5472.CAN-07-2837
52. Sideridou M, Zakopoulou R, Evangelou K, Liontos M, Kotsinas A, Rampakakis E, Gagos S, Kahata K, Grabusic K, Gkouskou K, et al. Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins. J Cell Biol 2011; 195:1123-40; PMID:22201124; http://dx.doi.org/10.1083/jcb.201108121
53. Gonzalez S, Klatt P, Delgado S, Conde E, Lopez-Rios F, Sanchez-Cespedes M, Mendez J, Antequera F, Serrano M. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 2006; 440:702-6; PMID:16572177; http://dx.doi.org/10.1038/nature04585
54. Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND. Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J 2005; 24:1157-69; PMID:15775976; http://dx.doi.org/10.1038/ sj.emboj.7600608
55. Monasor A, Murga M, Lopez-Contreras AJ, Navas C, Gomez G, Pisano DG, Fernandez-Capetillo O. INK4a/ARF limits the expansion of cells suffering from replication stress. Cell Cycle 2013; 12:1948-54; PMID:23676215; http://dx.doi.org/10.4161/cc.25017
56. Carlos AR, Escandell JM, Kotsantis P, Suwaki N, Bouwman P, Badie S, Folio C, Benitez J, Gomez-Lopez G, Pisano DG, et al. ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets. Nat Commun 2013; 4:2697; PMID:24162189; http://dx.doi.org/10.1038/ncomms3697
57. Maiguel DA, Jones L, Chakravarty D, Yang C, Carrier F. Nucleophosmin sets a threshold for p53 response to UV radiation. Mol Cell Biol 2004; 24:3703-11; PMID:15082766; http://dx.doi.org/10.1128/MCB.24.9.3703-3711.2004
58. Nalabothula N, Indig FE, Carrier F. The Nucleolus Takes Control of Protein Trafficking Under Cellular Stress. Mol Cell Pharmacol 2010; 2:203-12; PMID:21499571
59. Lu X, Nguyen TA, Moon SH, Darlington Y, Sommer M, Donehower LA. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metastasis Rev 2008; 27:123-35; PMID:18265945; http://dx.doi.org/10.1007/s10555-008-9127-x
60. Li Y, Wu D, Chen B, Ingram A, He L, Liu L, Zhu D, Kapoor A, Tang D. ATM activity contributes to the tumor-suppressing functions of p14ARF. Oncogene 2004; 23:7355-65; PMID:15258567; http://dx.doi.org/10.1038/sj.onc.1207957
61. Eymin B, Claverie P, Salon C, Leduc C, Col E, Brambilla E, Khochbin S, Gazzeri S. p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress. Mol Cell Biol 2006; 26:4339-50; PMID:16705183; http://dx.doi.org/10.1128/MCB.02240-05
62. Lindström MS, Zhang Y. B23 and ARF: friends or foes? Cell Biochem Biophys 2006; 46:79-90; PMID:16943625; http://dx.doi.org/10.1385/CBB:46:1:79
63. Orlando G, Khoronenkova SV, Dianova II, Parsons JL, Dianov GL. ARF induction in response to DNA strand breaks is regulated by PARP1. Nucleic Acids Res 2014; 42:2320-9; PMID:24293653; http://dx.doi.org/10.1093/nar/gkt1185
64. Paschalaki KE, Starke RD, Hu Y, Mercado N, Margariti A, Gorgoulis VG, Randi AM, Barnes PJ. Dysfunction of endothelial progenitor cells from smokers and COPD patients due to increased DNA damage and senescence. Stem Cells 2013; 31:2813-26; http://dx.doi.org/10.1002/stem.1488
65. Dolado I, Swat A, Ajenjo N, De Vita G, Cuadrado A, Nebreda AR. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 2007; 11:191-205; PMID:17292829; http://dx.doi.org/10.1016/j.ccr.2006.12.013
66. Deshpande SS, Angkeow P, Huang J, Ozaki M, Irani K. Rac1 inhibits TNF-alpha-induced endothelial cell apoptosis: dual regulation by reactive oxygen species. FASEB J 2000; 14:1705-14; PMID:10973919; http://dx.doi.org/10.1096/fj. 99-0910com
67. Savic-Radojevic A, Mimic-Oka J, Pljesa-Ercegovac M, Opacic M, Dragicevic D, Kravic T, Djokic M, Micic S, Simic T. Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder. Eur Urol 2007; 52:470-7; PMID:17267100; http://dx.doi.org/10.1016/j.eururo.2007.01.046
68. Hao CN, Geng YJ, Li F, Yang T, Su DF, Duan JL, Li Y. Insulin-like growth factor-1 receptor activation prevents hydrogen peroxide-induced oxidative stress, mitochondrial dysfunction and apoptosis. Apoptosis 2011; 16:1118-27; PMID:21785846; http://dx.doi.org/10.1007/s10495-011-0634-9
69. Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P. Aging, atherosclerosis, and IGF-1. J Gerontol A Biol Sci Med Sci 2012; 67:626-39; PMID:22491965; http://dx.doi.org/10.1093/gerona/gls102
70. Kim DK, Cho ES, Seong JK, Um HD. Adaptive concentrations of hydrogen peroxide suppress cell death by blocking the activation of SAPK/JNK pathway. J Cell Sci 2001; 114:4329-34; PMID:11739664
71. Kishi H, Nakagawa K, Matsumoto M, Suga M, Ando M, Taya Y, Yamaizumi M. Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38 MAPK without phosphorylation at Ser15 and Ser20. J Biol Chem 2001; 276:39115-22; PMID:11495913; http://dx.doi.org/10.1074/jbc.M105134200
72. Liu B, Chen Y, St Clair DK. ROS and p53: a versatile partnership. Free Radic Biol Med 2008; 44:1529-35; PMID:18275858; http://dx.doi.org/10.1016/j. freeradbiomed.2008.01.011
73. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 2007; 19:238-45; PMID:17303408; http://dx.doi.org/10.1016/j.ceb.2007.02.009
74. Wang B, Elledge SJ. Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc Natl Acad Sci U S A 2007; 104:20759-63; PMID:18077395; http://dx.doi.org/10.1073/ pnas.0710061104
75. Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev 2001; 15:1067-77; PMID:11331603; http://dx.doi.org/10.1101/gad.886901